anmelden
BX Swiss TOP 30 CHF
1.428,93
PKT
+17,88
PKT
+1,27
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.01.12 | UBS underperform | Exane-BNP Paribas SA | |
| 09.01.12 | Zurich Insurance buy | Nomura | |
| 09.01.12 | ABB (Asea Brown Boveri) neutral | HSBC | |
| 09.01.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 09.01.12 | Novartis hold | Vontobel Research | |
| 09.01.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 06.01.12 | UBS overweight | J.P. Morgan Cazenove | |
| 06.01.12 | UBS overweight | J.P. Morgan Cazenove | |
| 06.01.12 | UBS outperform | RBC Capital Markets | |
| 06.01.12 | UBS buy | Nomura | |
| 06.01.12 | UBS neutral | Nomura | |
| 05.01.12 | Novartis overweight | J.P. Morgan Cazenove | |
| 05.01.12 | Holcim neutral | Credit Suisse Group | |
| 04.01.12 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 04.01.12 | Givaudan sell | Deutsche Bank AG | |
| 04.01.12 | UBS hold | Deutsche Bank AG | |
| 04.01.12 | UBS hold | Deutsche Bank AG | |
| 04.01.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 04.01.12 | Novartis buy | Deutsche Bank AG | |
| 03.01.12 | Holcim neutral | Goldman Sachs Group Inc. | |
| 03.01.12 | Roche buy | Deutsche Bank AG | |
| 03.01.12 | Adecco SA buy | Vontobel Research | |
| 27.12.11 | Novartis kaufen | Raiffeisen Centrobank AG | |
| 27.12.11 | Swisscom hold | Vontobel Research | |
| 23.12.11 | ABB (Asea Brown Boveri) neutral | Sarasin Research | |
| 23.12.11 | Novartis neutral | Goldman Sachs Group Inc. | |
| 23.12.11 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 22.12.11 | Holcim hold | Deutsche Bank AG | |
| 22.12.11 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 22.12.11 | Holcim hold | Deutsche Bank AG | |
| 22.12.11 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 21.12.11 | UBS neutral | Credit Suisse Group | |
| 21.12.11 | Novartis overweight | J.P. Morgan Cazenove | |
| 21.12.11 | Richemont buy | Nomura | |
| 21.12.11 | Novartis hold | Vontobel Research | |
| 19.12.11 | Holcim hold | Deutsche Bank AG | |
| 19.12.11 | Holcim hold | Deutsche Bank AG | |
| 19.12.11 | Zurich Insurance buy | Nomura | |
| 16.12.11 | Novartis outperform | Credit Suisse Group | |
| 16.12.11 | Swiss Re overweight | J.P. Morgan Cazenove |